Steto
Stēto develops Remote Patient Monitoring solutions and Digital Therapies against diabetes. 800M people worldwide will be suffering from diabetes in 2045. Healthcare systems around the globe are looking for new care organisations to tackle the issue, going beyond the usual ‘appointment every X months’. Our mission at Stēto is to imagine new models that will allow every patient to receive the daily medical support they need, and build the digital tools to bring them to life. We are a team of passionate healthcare professionals and technical experts, working hand in hand to change the way diabetes is treated. Join us in the adventure !
Stēto develops Remote Patient Monitoring solutions and Digital Therapies against diabetes. 800M people worldwide will be suffering from diabetes in 2045. Healthcare systems around the globe are looking for new care organisations to tackle the issue, going beyond the usual ‘appointment every X months’. Our mission at Stēto is to imagine new models that will allow every patient to receive the daily medical support they need, and build the digital tools to bring them to life. We are a team of passionate healthcare professionals and technical experts, working hand in hand to change the way diabetes is treated. Join us in the adventure !
Steto has raised $1.3M across 1 round. Its most recent round was a Seed of $1.3M in Nov 2023. Full funding history, investors, and team are detailed below.
Funding history
1 round on record.
Unlock the lead investor and full details for this round.
People
Founders, executives, and decision-makers — sourced and refreshed weekly.
See who runs this company — founders and key execs, with titles and LinkedIn profiles, ready to export.
Steto is featured in
Similar companies
Dillico is a tech company focusing on creating innovative machinery to make the production of mRNA vaccines and medicines more efficient and accessible worldwide.
Parallel helps coding agent works side by side with hospital teams to deliver faster and more accurate medical coding.
Atrial fibrillation is the leading heart rhythm disorder. The best method to avoid it coming back is by undergoing an intervention called ablation. Ablation can be done using Radiofrequency or Cryoballoon, with the latter being a newer, quicker, and simpler technique. However, Cryoballoon ablation carries the risk of causing Diaphragmatic Paralysis. Circle Safe is working on a solution to eradicate this complication entirely.
Lyv assists individuals who are experiencing suffering.
MEDIAN Technologies develops medical imaging software and services dedicated to oncology clinical trials, cancer screening, and clinical practice. The company standardizes and automates the interpretation of medical images in oncology to optimize the diagnosis of cancer patients and the assessment of their response to therapy. The company serves two primary markets: drug development and patient care. MEDIAN Technologies has a strategic partnership with a contract research organization to offer integrated imaging services for clinical trials to biopharma sponsors worldwide, and a strategic partnership with Canon to develop new imaging technologies, and to address the patient care market. MEDIAN Technologies was founded in 2002 and is based in Sophia-Antipolis, France.
Kwit creates scientific methods for quitting smoking and provides daily support with positivity and compassion.
Robeaute is a research and development agency that creates neurosurgical microrobots capable of adjusting to various forms of medical data.
A first-in-class pipeline of small compounds aimed at the cancer's overall metabolism is being created by BiPER Therapeutics. The company's main substance, BPR001, is a first-in-class small molecule therapy that targets the oncogenic protein BiP, which has been proven to play a significant role in cancer through the control of endoplasmic reticulum stress.
CILcare specializes in providing drug solutions for hearing and ear disorders.
Jinko offers personalized supportive assistance to individuals affected by cancer.
Moria creates, produces, and sells ophthalmic surgery equipment and instruments for refractive and reconstructive procedures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.